BMBL
Bumble Inc.
BMBL trails on the overall score without a compensating advantage in the available component scores.
NVDA
NVIDIA Corporation
NVDA has the edge over BMBL overall, supported by stronger fundamentals and stronger valuation.
BMBL Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| Strong | |
| Healthy |
BMBL's cash flow and balance sheet are currently healthy, but its revenue and profitability are under pressure.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
BMBL PE Valuation
BMBL has no meaningful PE right now: it lost money over the past year.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA's PE is in its cheap range at 21x. If earnings grow as analysts expect, today's price would be 12x next year's earnings.
BMBL Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong decline | |
| Decline | |
| Strongly weakening | |
| Limited | |
| Low |
Analysts expect BMBL's earnings and revenue to decline, with profitability weakening. However, they disagree widely on these estimates.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
NVDA has the edge over BMBL on the outlook, with more favorable earnings and revenue expectations.
BMBL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.63 | — |
| Q3 2026 | -$4.26 | -$2.36 |
| Q2 2026 | -$4.13 | +$3.21 |
| Q1 2026 | -$5.74 | -$1.07 |
| Q4 2025 | -$5.95 | -$1.34 |
| Q3 2025 | -$1.90 | +$2.99 |
| Q2 2025 | -$7.34 | -2259% |
| Q1 2025 | -$4.67 | -2847% |
| Q4 2024 | -$4.61 | -$4.58 |
BMBL is still losing money, but less than at its worst: $4.26 per share over the past year, against $7.34 at its worst in mid-2025.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over BMBL on earnings quality, reporting a profit while its opponent remains loss making.
BMBL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $207.1M | -16% |
| Q2 2026 | $210.5M | -15% |
| Q1 2026 | $212.4M | -14% |
| Q4 2025 | $224.2M | -14% |
| Q3 2025 | $246.2M | -10% |
| Q2 2025 | $248.2M | -7.6% |
| Q1 2025 | $247.1M | -7.7% |
| Q4 2024 | $261.6M | -4.4% |
BMBL's revenue has slid since its 2023 peak: $207M last quarter, down 16% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 26% | +0.5 points |
| Q2 2026 | -53% | +83 points |
| Q1 2026 | 31% | +13 points |
| Q4 2025 | -257% | -271 points |
| Q3 2025 | 26% | +332 points |
| Q2 2025 | -136% | -156 points |
| Q1 2025 | 18% | -0.1 points |
| Q4 2024 | 14% | +17 points |
BMBL's operating margin was 26% last quarter, about level with the same quarter a year ago, near the top of its range since 2019.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over BMBL on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over BMBL on profitability, with a higher operating margin.
BMBL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $56M | -27% |
| Q2 2026 | $53.6M | -25% |
| Q1 2026 | $77.2M | +79% |
| Q4 2025 | $59.1M | +$64.5M |
| Q3 2025 | $76.8M | -18% |
| Q2 2025 | $71.2M | +116% |
| Q1 2025 | $43.2M | +1687% |
| Q4 2024 | -$5.4M | -109% |
BMBL generated $246M in free cash flow over the past year, up 32% from the year before.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over BMBL on cash flow, with more consistent year-over-year improvement.
BMBL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.1% | +1.4M shares |
| 1 year | +28% | +28.9M shares |
| 3 years | +0.4% | +497K shares |
| 5 years | +19% | +20.7M shares |
BMBL has 132M diluted shares, up 28% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $28.7M |
| Q4 2024 | $40.3M |
BMBL hasn't bought back shares in the past year.
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has the edge over BMBL on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
BMBL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2024 | 1.7x | Healthy |
| Q1 2024 | 2.2x | Moderate |
| Q4 2023 | 2.2x | Moderate |
| Q3 2022 | 1.9x | Healthy |
| Q2 2022 | 2.6x | Moderate |
| Q1 2022 | 3.0x | Elevated |
| Q4 2020 | 9.0x | High |
| Q3 2020 | 4.2x | High |
BMBL's net debt is about 1.7 years of its operating earnings (EBITDA), down from 2.6 years a year ago.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
BMBL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 77.0 | Overbought |
| Stochastic | 99.3 | Overbought |
BMBL's weekly RSI is 77 (overbought) and its Stochastic is 99 (overbought).
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
BMBL PE vs Technology Sector
| Metric | BMBL | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
BMBL has no meaningful PE right now: it lost money over the past year.
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA is trading at 21x earnings, a 25% discount to the Technology sector's median of 28x.
BMBL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.70 | 28% above |
| 20 week MA | $3.61 | 66% above |
| 50 week MA | $3.47 | 73% above |
| 100 week MA | $4.71 | 28% above |
| 200 week MA | $9.16 | 34% below |
BMBL has the edge over NVDA on trend strength, trading above more of its moving averages.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has fallen below most of its moving averages, though it's still 34% above its 200-week average.
BMBL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $75.5 | $34.9 | -54% |
| 2022 | $34.9 | $20.9 | -40% |
| 2023 | $20.9 | $14.7 | -30% |
| 2024 | $14.7 | $8.02 | -46% |
| 2025 | $8.02 | $3.52 | -56% |
| 2026 YTD | $3.52 | $6.01 | +71% |
BMBL has the edge over NVDA on returns for 2026, with the stronger performance.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA's yearly returns have swung widely, from +226% in 2023 to −49% in 2022. It's down 13% so far in 2026.